Immuneering Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Immuneering Corporation
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IMRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001790340
Board of directors
-
Ann E. Berman · DirectorSince 2023
-
Benjamin J. Zeskind · Director · PRESIDENT AND CEOSince 2023
-
Diana Hausman · DirectorSince 2023
-
Laurie Keating · DirectorSince 2023
-
Peter Feinberg · DirectorSince 2023
-
Robert J. Carpenter · DirectorSince 2023
-
Thomas J. Schall · DirectorSince 2024
Chief executives
Benjamin J. Zeskind
· PRESIDENT AND CEO
Dates unknown
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.9%
-
95.4%
Board connections
3 of this board's directors also sit on 4 other boards.
- via Laurie Keating
- via Ann E. Berman
- via Laurie Keating
- via Diana Hausman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $423,099
- 13 purchases by 8 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Benjamin J. Zeskind Director, Officer (PRESIDENT AND CEO) | Open-market purchase | +2,400 | $4.56 | $10,944 |
| Jun 15, 2026 | Hall Brett Matthew Officer (CHIEF SCIENTIFIC OFFICER) | Open-market purchase | +6,035 | $4.15 | $25,045 |
| Mar 13, 2026 | Neufeld Leah R Officer (CHIEF PEOPLE OFFICER) | Grant or award | +3,628 | $4.29 | $15,564 |
| Jan 16, 2026 | Brakewood Harold Eugene Officer (Chief Business Officer) | Open-market purchase | +5,250 | $4.76 | $24,990 |
| Jan 15, 2026 | Thomas J. Schall Director | Open-market purchase | +21,645 | $4.67 | $101,082 |
| Jan 15, 2026 | Hall Brett Matthew Officer (CHIEF SCIENTIFIC OFFICER) | Open-market purchase | +2,298 | $4.57 | $10,502 |
| Jan 13, 2026 | Neufeld Leah R Officer (CHIEF PEOPLE OFFICER) | Open-market purchase | +2,626 | $4.15 | $10,898 |
| Jan 12, 2026 | Peter Feinberg Director | Open-market purchase | +20,000 | $4.35 | $87,000 |
| Oct 3, 2025 | Peter Feinberg Director | Open-market purchase | +7,500 | $6.67 | $50,025 |
| Oct 1, 2025 | Morales Mallory Officer (Chief Accounting Officer) | Open-market purchase | +300 | $6.39 | $1,917 |
| Oct 1, 2025 | Neufeld Leah R Officer (CHIEF PEOPLE OFFICER) | Open-market purchase | +800 | $6.38 | $5,104 |
| Oct 1, 2025 | Bookman Michael Officer (CHIEF LEGAL OFFICER, SECRETARY) | Open-market purchase | +1,020 | $6.83 | $6,967 |
| Sep 30, 2025 | Peter Feinberg Director | Open-market purchase | +7,500 | $7.03 | $52,725 |
| Sep 29, 2025 | Peter Feinberg Director | Open-market purchase | +5,000 | $7.18 | $35,900 |
| Sep 15, 2025 | Neufeld Leah R Officer (CHIEF PEOPLE OFFICER) | Grant or award | +11,815 | $1.43 | $16,895 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.